These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32507592)

  • 1. Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association.
    Brown EE; Sturm AC; Cuchel M; Braun LT; Duell PB; Underberg JA; Jacobson TA; Hegele RA
    J Clin Lipidol; 2020; 14(4):398-413. PubMed ID: 32507592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2019 George Lyman Duff Memorial Lecture: Three Decades of Examining DNA in Patients With Dyslipidemia.
    Hegele RA; Dron JS
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):1970-1981. PubMed ID: 32762461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of genetic testing in dyslipidaemia.
    Berberich AJ; Hegele RA
    Pathology; 2019 Feb; 51(2):184-192. PubMed ID: 30558903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can genetic testing help in the management of dyslipidaemias?
    Lazarte J; Hegele RA
    Curr Opin Lipidol; 2020 Aug; 31(4):187-193. PubMed ID: 32520779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of genetic testing for lipid disorders.
    Muzurović E; Borozan S; Rizzo M
    Curr Opin Cardiol; 2024 May; 39(3):154-161. PubMed ID: 38456469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted next-generation sequencing in monogenic dyslipidemias.
    Hegele RA; Ban MR; Cao H; McIntyre AD; Robinson JF; Wang J
    Curr Opin Lipidol; 2015 Apr; 26(2):103-13. PubMed ID: 25692347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the molecular biology of dyslipidemias.
    Ramasamy I
    Clin Chim Acta; 2016 Feb; 454():143-85. PubMed ID: 26546829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Modern Approach to Dyslipidemia.
    Berberich AJ; Hegele RA
    Endocr Rev; 2022 Jul; 43(4):611-653. PubMed ID: 34676866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The advantages and pitfalls of genetic analysis in the diagnosis and management of lipid disorders.
    Berberich AJ; Hegele RA
    Best Pract Res Clin Endocrinol Metab; 2023 May; 37(3):101719. PubMed ID: 36641373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polygenic risk scores for the diagnosis and management of dyslipidemia.
    Brunham LR; Trinder M
    Curr Opin Endocrinol Diabetes Obes; 2022 Apr; 29(2):95-100. PubMed ID: 35034034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polygenic scores for dyslipidemia: the emerging genomic model of plasma lipoprotein trait inheritance.
    Trinder M; Brunham LR
    Curr Opin Lipidol; 2021 Apr; 32(2):103-111. PubMed ID: 33395106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetics of dyslipidemia--yesterday, today, and tomorrow].
    Hubácek JA; Vrablík M
    Vnitr Lek; 2007 Apr; 53(4):371-6. PubMed ID: 17578168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias.
    Johansen CT; Dubé JB; Loyzer MN; MacDonald A; Carter DE; McIntyre AD; Cao H; Wang J; Robinson JF; Hegele RA
    J Lipid Res; 2014 Apr; 55(4):765-72. PubMed ID: 24503134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARY
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M; Zangeneh F; Bush MA
    Endocr Pract; 2017 Apr; 23(4):479-497. PubMed ID: 28156151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic testing in dyslipidaemia: An approach based on clinical experience.
    Berberich AJ; Hegele RA
    Best Pract Res Clin Endocrinol Metab; 2023 May; 37(3):101720. PubMed ID: 36682941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exome sequencing in suspected monogenic dyslipidemias.
    Stitziel NO; Peloso GM; Abifadel M; Cefalu AB; Fouchier S; Motazacker MM; Tada H; Larach DB; Awan Z; Haller JF; Pullinger CR; Varret M; Rabès JP; Noto D; Tarugi P; Kawashiri MA; Nohara A; Yamagishi M; Risman M; Deo R; Ruel I; Shendure J; Nickerson DA; Wilson JG; Rich SS; Gupta N; Farlow DN; Neale BM; Daly MJ; Kane JP; Freeman MW; Genest J; Rader DJ; Mabuchi H; Kastelein JJ; Hovingh GK; Averna MR; Gabriel S; Boileau C; Kathiresan S
    Circ Cardiovasc Genet; 2015 Apr; 8(2):343-50. PubMed ID: 25632026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The brave new world of genetic testing in the management of the dyslipidaemias.
    Nawawi HM; Chua YA; Watts GF
    Curr Opin Cardiol; 2020 May; 35(3):226-233. PubMed ID: 32097179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US Preventive Services Task Force.
    Haney EM; Huffman LH; Bougatsos C; Freeman M; Steiner RD; Nelson HD
    Pediatrics; 2007 Jul; 120(1):e189-214. PubMed ID: 17606543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Contribution of GWAS Loci in Familial Dyslipidemias.
    Ripatti P; Rämö JT; Söderlund S; Surakka I; Matikainen N; Pirinen M; Pajukanta P; Sarin AP; Service SK; Laurila PP; Ehnholm C; Salomaa V; Wilson RK; Palotie A; Freimer NB; Taskinen MR; Ripatti S
    PLoS Genet; 2016 May; 12(5):e1006078. PubMed ID: 27227539
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.